ALK and T-cell non-Hodgkin lymphoma: To seek an explanation for the more pronounced effects of combination treatment with PPP and ASP3026, we measured phosphorylation levels of IGF-IR, NPM-ALK, and STAT3 in NPM-ALK+ T cell lymphoma cells.